Cargando…
Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?
Today, scientists are often encouraged to custom-design vaccines based on a particular country or clade. Here, we review the scientific literature and then suggest that the overwhelming endeavor to produce a unique vaccine for every world region or virus subtype may not be necessary.
Autores principales: | Slobod, Karen S, Coleclough, Chris, Brown, Scott A, Stambas, John, Zhan, Xiaoyan, Surman, Sherri, Jones, Bart G, Zirkel, Amy, Freiden, Pamela J, Brown, Brita, Sealy, Robert, Bonsignori, Mattia, Hurwitz, Julia L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1112584/ https://www.ncbi.nlm.nih.gov/pubmed/15860130 http://dx.doi.org/10.1186/1742-6405-2-3 |
Ejemplares similares
-
Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials
por: Brown, Scott A., et al.
Publicado: (2010) -
HIV-1 envelope accessible surface and polarity: clade, blood, and brain
por: Sowmya, Gopichandran, et al.
Publicado: (2011) -
Respiratory Syncytial Virus: Current Progress in Vaccine Development
por: Rudraraju, Rajeev, et al.
Publicado: (2013) -
The breast cancer microenvironment and lipoprotein lipase: Another negative notch for a beneficial enzyme?
por: Bavis, Makayla M., et al.
Publicado: (2023) -
Nuclear Receptors, Ligands and the Mammalian B Cell
por: Jones, Bart G., et al.
Publicado: (2020)